Intelligence Platform
Patents
Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7348314
Compositions and methods for inhibiting viral replication
granted patentUS 7344711
Use of adenoviruses mutated in the VA genes for cancer treatment
granted patentUS 7344722
Cold-adapted influenza virus
granted patentUS 7339037
Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, v
granted patentUS 7332170
Classical swine fever virus virulence determinant and a novel classical swine fever vaccin
granted patentUS 7332321
Viral fibers
granted patentUS 7314858
Retrocyclins: antiviral and antimicrobial peptides
granted patentUS 7314631
Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect agains
granted patentUS 7309495
Hemorrhagic feline calicivirus
granted patentUS 7300650
Reovirus for the treatment of neoplasia
granted patentUS 7288369
Replication competent hepatitis C virus and methods of use
granted patentUS 7285383
Method for selective inactivation of viral replication
granted patentUS 7282205
Anti-hepatitis A virus antibodies
granted patentUS 7279306
Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferabl
granted patentUS 7276227
Obligate domain-swapped dimer of cyanovirin with enhanced anti-viral activity
granted patentUS 7273613
Diagnostics and therapy of Epstein-Barr virus in autoimmune disorders
granted patentUS 7267941
Cyanovirin variant-polymer conjugates
granted patentUS 7264816
Virulent systemic feline calicivirus
granted patentUS 7264798
Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
granted patentUS 7252989
Adenovirus supervector system
granted patentUS 7252817
Viruses for the treatment of cellular proliferative disorders
granted patentUS 7250171
Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprote
granted patentUS 7244435
DNA vaccine expressing HA1 of equine-2 influenza virus
granted patentUS 7244617
Diminishing viral gene expression by promoter replacement
granted